SETD2 and nonpapillary renal cell carcinoma: Taken together, we speculate that SETD2 mutations may mediate immune silencing, while BAP1 mutations may be involved in regulating T-cell infiltration and exhaustion in the TIME in ccRCC (Figure 3B).